BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 43 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $7,096,000 | +289.0% | 6,859,000 | +323.9% | 0.06% | +323.1% |
| Q2 2019 | $1,824,000 | +9.4% | 1,618,000 | +10.7% | 0.01% | -7.1% |
| Q1 2019 | $1,668,000 | +3968.3% | 1,462,000 | +4077.1% | 0.01% | – |
| Q2 2018 | $41,000 | -98.0% | 35,000 | -98.0% | 0.00% | -100.0% |
| Q1 2017 | $2,098,000 | -30.8% | 1,768,000 | -26.8% | 0.02% | 0.0% |
| Q3 2016 | $3,030,000 | +273.2% | 2,414,000 | +300.3% | 0.02% | +220.0% |
| Q4 2015 | $812,000 | -86.3% | 603,000 | -84.6% | 0.01% | -84.8% |
| Q1 2015 | $5,939,000 | +180.9% | 3,922,000 | +103.1% | 0.03% | +135.7% |
| Q3 2014 | $2,114,000 | +4597.8% | 1,931,000 | +4497.6% | 0.01% | – |
| Q4 2013 | $45,000 | – | 42,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCHRODER INVESTMENT MANAGEMENT GROUP | 12,400,000 | $1,340,750,000,000 | 1.66% |
| OAKTREE CAPITAL MANAGEMENT LP | 66,800,000 | $70,446,000 | 1.23% |
| Man Investments (CH) AG | 2,600,000 | $2,743,000 | 1.11% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $8,425,000 | 0.81% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 35,763,000 | $38,870,000 | 0.58% |
| Jabre Capital Partners S.A. | 5,900,000 | $6,240,000 | 0.44% |
| SSI INVESTMENT MANAGEMENT LLC | 3,039,000 | $3,198,000 | 0.31% |
| AVIVA PLC | 37,700,000 | $39,724,000 | 0.30% |
| BNP PARIBAS FINANCIAL MARKETS | 3,000,000 | $315,929,984,000 | 0.30% |
| Calamos Advisors LLC | 44,222,000 | $46,596,000 | 0.30% |